Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC). | Histopathology | 2023 | 37488782 | PubTator, text mining | PubMed |
| A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report. | BMC Med Genomics | 2023 | 37488596 | PubTator, text mining | PubMed |
| Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease. | PLoS One | 2023 | 37471416 | PubTator, text mining | PubMed |
| Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy. | Front Mol Biosci | 2023 | 37469705 | PubTator, text mining | PubMed |
| Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring. | Eur Heart J Cardiovasc Imaging | 2023 | 37467476 | PubTator, text mining | PubMed |
| Maternal hepatic immunology during pregnancy. | Front Immunol | 2023 | 37457700 | PubTator, text mining | PubMed |
| Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products. | Front Immunol | 2023 | 37457696 | PubTator, text mining | PubMed |
| Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. | JHEP Rep | 2023 | 37456676 | PubTator, text mining | PubMed |
| The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review). | Int J Mol Med | 2023 | 37449492 | PubTator, text mining | PubMed |
| A novel 6-day cycle surgical pathology rotation improves resident satisfaction and maintains Accreditation Council for Graduate Medical Education (ACGME) milestone performance. | Acad Pathol | 2023 | 37448760 | PubTator, text mining | PubMed |
| Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation. | J Clin Med | 2023 | 37445489 | PubTator, text mining | PubMed |
| Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy. | J Clin Med | 2023 | 37445442 | PubTator, text mining | PubMed |
| Barriers and Facilitators to Pediatric Resident Education in the Emergency Department: A Qualitative Study. | Cureus | 2023 | 37425526 | PubTator, text mining | PubMed |
| Reconstitution of ATP-dependent lipid transporters: gaining insight into molecular characteristics, regulation, and mechanisms. | Biosci Rep | 2023 | 37417269 | PubTator, text mining | PubMed |
| Maternal hyperglycemia induces alterations in hepatic amino acid, glucose and lipid metabolism of neonatal offspring: Multi-omics insights from a diabetic pig model. | Mol Metab | 2023 | 37414142 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis. | J Clin Transl Hepatol | 2023 | 37408803 | PubTator, text mining | PubMed |
| SLC25A40 Facilitates Anticancer Drug Resistance in Human Leukemia K562 Cells. | Biol Pharm Bull | 2023 | 37407483 | PubTator, text mining | PubMed |
| Characteristics of Neuroimaging and Behavioural Phenotype in Polish Patients with PIGV-CDG-An Observational Study and Literature Review. | Genes (Basel) | 2023 | 37372388 | PubTator, text mining | PubMed |
| Current Therapies for Cholestatic Diseases. | Biomedicines | 2023 | 37371808 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review. | Cancers (Basel) | 2023 | 37370764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=14